Prostaglandin E1 decreases human arterial accumulation of radiolabeled apo B-containing lipoproteins in vivo

European Journal of Clinical Pharmacology

Volumn 52, Issue 3, 1997, Pages 191-197

  Kritz, H ^a   Sinzinger, H ^a,b   Lupattelli, G ^c   Virgolini, I ^b   Fitscha, P ^d   O'Grady, J ^b  

^a Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF PERUGIA   (Italy)

^d 2nd Department of Internal Medicine   (Austria)

Author keywords

Arterial apo B containing lipoprotein influx; Atherosclerosis; Cholesterol; Lesional imaging; Prostaglandin E1; low density lipoprotein

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTAGLANDIN E1; APOLIPOPROTEIN B; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; RADIOACTIVE IODINE; TRIACYLGLYCEROL;

ANTIBODY AFFINITY; ARTICLE; ATHEROGENESIS; CHROMATOGRAPHY; CLINICAL ARTICLE; COMPUTER SYSTEM; DIAGNOSTIC ACCURACY; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; REGRESSION ANALYSIS; ARTERIOSCLEROSIS; CAROTID ARTERY; DRUG EFFECT; FEMALE; FEMORAL ARTERY; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MIDDLE AGED;

ALPROSTADIL; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL; FEMALE; FEMORAL ARTERY; HUMANS; INFUSIONS, INTRAVENOUS; IODINE RADIOISOTOPES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0030610155     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050273     Document Type: Article

References (31)

1. Sinzinger H, Virgolini I (1990) Nuclear medicine and atherosclerosis. Eur J Nucl Med 17: 160-178
2. Alavi M, Moore S (1984) Kinetics of low density lipoprotein interactions with rabbit aortic wall following balloon catheter deendothelialization. Atherosclerosis 68: 395-402
3. Bratzler RL, Chisholm CM, Colton CK, Smith KA, Lees RS (1977) The distribution of labeled low-density lipoproteins across the rabbit thoracic aorta in vivo. Atherosclerosis 28: 289-307
4. Ghos S (1979) Transport of lipoproteins into the artery. Artery 5: 354-361
5. Anitschkow N (1913) Über die Veränderung der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beitr Pathol Anat 56: 379-391
6. St Clair RW (1976) Metabolism of the arterial wall and atherosclerosis. In: Paoletti F, Gotto AM (eds) Atherosclerosis reviews. Raven Press, New York, pp 161-177
7. 99mTc-labeled lipoprotein metabolism and non-invasive imaging of atherosclerotic lesions. Eur J Nucl Med 4: 198
8. Vallabhajosula S, Paidi M, Badimon JJ, Le NA, Goldsmith SJ, Fuster V, Ginsberg HN (1988) Radiotracer for low-density lipoprotein biodistribution. Studies in vivo: technetium 99m low-density lipoprotein versus radio-iodinated low-density lipoprotein preparations. J Nucl Med 29: 1237-1245
9. Hoff HH, Bradley WA, Heideman CL, Gaubatz HW, Karagas MD, Gotto AM (1979) Characterization of low-density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions. Biochim Biophys Acta 573: 361-347
10. Sinzinger H, Angelberger P (1988) Imaging and kinetic studies with radiolabelled autologous low-density lipoproteins (LDL) in human atherosclerosis. Nucl Med Commun 9: 859-866
11. Lees RS, Garabedian H, Lees AM (1985) Technetium low-density lipoprotein: preparation and biodistribution. J Nucl Med 26: 1056-1062
12. Willis AL, Smith DL, Vigo C (1986) Suppression of principal atherosclerotic mechanisms by prostacyclin and other eicosanoids. Prog Lipid Res 48: 1-22
13. 1 suppress sterol synthesis in freshly isolated human mononuclear leukocytes. Biochim Biophys Acta 835: 154-157
14. 1) decreases the low-density lipoprotein (LDL) entry into rabbit arterial wall. Br J Pharmacol 103: 1626-1628
15. 1 decreases low-density lipoprotein influx into rabbit aorta. Eur J Pharmacol 219: 129-133
16. Kaliman J, Kostner G, Kraupp O, Kunze M, Sinzinger H, Widhalm K (1987) Guidelines for prevention of atherosclerosis. Wien Klin Wochenschr 99: 589-990
17. McFarlane AS (1958) Efficient tracer labelling of proteins with iodine. Nature 182: 53-57
18. Hajjar DP, Weksler BB, Falcone DJ, Hefton JM, Minick CR (1982) Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. J Clin Invest 70: 479-488
19. 1. J Lipid Res 24: 1176-1185
20. Hajjar DP (1985) Prostaglandins and cyclic nucleotides. Modulators of arterial cholesterol metabolism. Biochem Pharmacol 34: 295-300
21. Ross JM, Glomset JA, Kariya B, Harker L (1974) A platelet dependent serum factor that stimulates the proliferation of smooth muscle cells in vitro. Proc Natl Acad Sci USA 71: 1207-1210
22. Coughlin SR, Moskwith MA, Zeller BR, Antoniades HN, Levin D (1980) Platelet dependent stimulation of prostacyclin synthesis by platelet derived growth factor. Nature 188: 5791-5794
23. Smith DL, Willis AL, Nauyen N, Dave S, Yih R, Nakamura G (1986) Antiatherosclerotic properties of prostacyclin on release of mitogens from platelets and endothelial cells. Excerpta Med Int Congr Ser 696: 453-456
24. Hajjar DP, Marcus Ai, Hajjar KA (1991) Arterial endothelial cell-derived eicosanoids alter cholesterol metabolism in arterial smooth muscle cells. Ann NY Acad Sci 421: 411-413
25. Kruth HS (1985) Platelet mediated cholesterol accumulation in cultured smooth muscle cells. Science 227: 1243-1245
26. Faggiottto A, Ross R (1984) Studies of hypercholesterolemia in the non-human primate. Explanation of fatty streak conversion of the fibrous plaque. Arteriosclerosis 4: 341-356
27. Lees RS, Lees AM, Strauss HW (1983) External imaging of human atherosclerosis. J Nucl Med 24: 154-156
28. Virgolini I, Rauscha F, Lupattelli G, Angelberger P, Ventura A, O'Grady J, Sinzinger H (1991) Autologous low-density lipoprotein labeling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 18: 948-951
29. Lees AM, Lees RS, Schoen FJ (1988) Imaging human atherosclerosis with 99m Tc-labeled low-density lipoproteins. Arteriosclerosis 8: 461-470
30. Virgolini I, Angelberger P, O'Grady H, Sinzinger H (1991) Low-density lipoprotein labeling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 17: 944-947
31. Willis AL, Smith DL, Vigo C, Kluge AF (1986) Effects of prostacyclin and orally active stable mimetic acten RS-93427-007 on basic mechanisms of atherosclerosis. Lancet ii: 682-683